Sanjivani Paranteral Ltd

NSE: SANJIVIN · BSE: 531569 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹169.05
Market cap: ₹207.7 Cr
Revenue (annual): ₹68.67 Cr
Net profit (annual): ₹6.79 Cr
P/E (TTM): 19.7×Sector 50.4×
Promoter holding: 31.56%+0.30% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Fund Raise 1 Financial Results 1 Earnings Call 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

23 Sep 2026 15:48 IST BSE

Fund RaiseAlfa Alert

Sanjivani Paranteral Fund Raise

Sanjivani Paranteral clarified the objects of its proposed 5 lakh convertible warrant issue to BSE. Proceeds of ~₹5.80 Cr will fund capex and subsidiary working capital for expansion.

Read the story on ALFA News Read the filing ↗